Comparison of metabolic parameters during treatment for schizophrenia with olanzapine intramuscular long-acting injection versus olanzapine oral formulation

被引：0
作者：
Gulliver, A. [1 ]
McDonnell, D. P. [1 ]
Kryzhanovskaya, L. A. [1 ]
Zhao, F. [1 ]
Detke, H. C. [1 ]
Feldman, P. D. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [41] IMPROVEMENT IN PATIENT SYMPTOMS AND FUNCTIONING DURING LONG-TERM TREATMENT WITH OLANZAPINE LONG-ACTING INJECTION (OLAI)
    Peuskens, J.
    Porsdal, V.
    Pecenak, J.
    Handest, P.
    D'yachkova, Y.
    Brousil, R.
    Casillas, M.
    Deberdt, W.
    [J]. EUROPEAN PSYCHIATRY, 2011, 26
  • [42] Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
    Wehring, Heidi J.
    Thedford, Sheryl
    Koola, Maju
    Kelly, Deanna L.
    [J]. JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 107 - 123
  • [43] Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses
    Ciudad, Antonio
    Anand, Ernie
    Berggren, Lovisa
    Casillas, Marta
    Schacht, Alexander
    Perrin, Elena
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1737 - 1750
  • [44] Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
    Witte, Michael M.
    Case, Michael G.
    Schuh, Kory J.
    Ascher-Svanum, Haya
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 315 - 323
  • [45] EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA
    Ascher-Svanum, H.
    Zhao, F.
    Nyhuis, A.
    Lawson, A. H.
    Stauffer, V. L.
    Montgomery, W.
    Witte, M.
    Detke, H.
    McDonnell, D. P.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A553 - A553
  • [46] Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia
    Olivares, Jose M.
    Pinal, Beatriz
    Cinos, Carmen
    [J]. NEUROPSYCHIATRY, 2011, 1 (03) : 275 - 289
  • [47] Injection-related adverse events observed with olanzapine long-acting injection
    Gulliver, A.
    McDonnell, D. P.
    Sorsaburu, S.
    Brunner, E.
    Detke, H. C.
    Andersen, S. W.
    Bergstrom, R. F.
    Mitchell, M.
    Ogle, K.
    Stickelmeyer, M. P.
    Corya, S. A.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 152 - 152
  • [48] Update: Post-injection syndrome observed with olanzapine long-acting injection
    Detke, H.
    Mcdonnell, D.
    Brunner, E.
    Watson, S.
    Kothare, P.
    Treuer, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 244 - 244
  • [49] OLANZAPINE "LONG-ACTING" IN MAINTENANCE THERAPY OF SCHIZOPHRENIA: A STUDY WITH PLASMA LEVELS
    Altamura, A. C.
    Rovera, Chiara
    Di Pace, C.
    Paletta, S.
    De Gaspari, I. F.
    MAuri, M. C.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S299 - S300
  • [50] "Long-acting" olanzapine in maintenance therapy of schizophrenia: A study with plasma levels
    Mauri, Massimo C.
    Maffini, Michele
    Di Pace, Chiara
    Reggiori, Alessandra
    Paletta, Silvia
    Moliterno, Donatella
    Rovera, Chiara
    Altamura, Carlo A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2015, 19 (02) : 99 - 105
12345